T. Yanagawa

Tumor vessel-injuring ability improves antitumor effect of cytotoxic T lymphocytes in adoptive immunotherapy

S. Nakagawa, N. Okada, T. Nakagawa, 2012, Cancer Gene Therapy.

Tumor-targeting CTL expressing a single-chain Fv specific for VEGFR2.

Y. Yoshioka, S. Nakagawa, N. Okada, 2010, Biochemical and biophysical research communications.

Cotransduction of CCL27 gene can improve the efficacy and safety of IL-12 gene therapy for cancer

Y. Tsutsumi, S. Nakagawa, T. Mayumi, 2007, Gene Therapy.

Parathyroid hormone (PTH) down-regulates PTH/PTH-related protein receptor gene expression in UMR-106 osteoblast-like cells via a 3',5'-cyclic adenosine monophosphate-dependent, protein kinase A-independent pathway.

Y. Fujii‐Kuriyama, N. Horiuchi, T. Kawane, 2003, The Journal of endocrinology.

Antitumor mechanism of intratumoral injection with IL-12-expressing adenoviral vector against IL-12-unresponsive tumor.

Y. Yoshioka, S. Nakagawa, Jianqing Gao, 2008, Biochemical and biophysical research communications.

E6130, a Novel CX3C Chemokine Receptor 1 (CX3CR1) Modulator, Attenuates Mucosal Inflammation and Reduces CX3CR1+ Leukocyte Trafficking in Mice with Colitis

T. Imai, H. Wakita, Y. Kuboi, 2017, Molecular Pharmacology.

novel CX 3 CR 1 modulator , attenuates mucosal inflammation and reduces CX 3 CR 1 + leukocyte trafficking in mice with colitis

T. Imai, H. Wakita, Y. Kuboi, 2017 .